NEW YORK (GenomeWeb) – Cepheid has received CE marking on a rapid test for influenza and respiratory syncytial virus, the firm announced today, and the new test is available immediately in all countries recognizing the CE mark.

The Xpert Xpress Flu/RSV runs on the firm's GeneXpert platform and provides results in about 30 minutes. The assay features a novel design employing multiple targets for each virus, with redundancy providing high sensitivity and mitigating the impact of seasonal drift, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.